USFDA flags Indian CRO over data falsification, sparks fresh scrutiny

In an untitled letter issued in March, the regulator declared all in vitro data generated by CRO Raptim Research as unreliable and asked an undisclosed number of pharmaceutical companies to repeat the studies conducted by the firm.

Source